Wed, Nov 26, 2014, 9:21 AM EST - U.S. Markets open in 9 mins.


% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • swhitemd50 swhitemd50 Dec 20, 2011 11:08 PM Flag


    I agree that the VRUS projections of growth in the HCV market are probably way too high but I think there is some truth to the idea that the market may grow significantly. I recall reading that most of the 4 million infected with HCV in the U.S. are unaware they have the virus. Now that effective treatments have reached the market, there will likely be more testing for HCV and the number seeking treatment should increase. Vertex and other HCV drug makers should all benefit from this. Vertex management has said they expect a fragmented HCV market in the next several years and I would assume their goal is to capture as many of these "fragments" as they can--especially the more difficult to treat cases. And with more testing and screening for HCV, all parts of this fragmented market should grow.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
114.19Nov 25 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million. International Ltd.
NasdaqGSTue, Nov 25, 2014 4:00 PM EST
Jarden Corp.
NYSETue, Nov 25, 2014 4:00 PM EST